MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER

QR Code

MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER

The review presents the mechanisms involved in the biological behavior of rectal cancer cells. The tumor response to neoadjuvant chemoradiotherapy was evaluated. The characteristics of proliferative activity, apoptosis, cell adhesion, and migration of rectal cancer cells influenced by chemotherapy w...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. R. Altybaev, S. G. Afanasyev, M. V. Zavyalova, I. V. Stepanov, D. A. Sorokin
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-11-01
Series:	Сибирский онкологический журнал
Subjects:	rectal cancer neoadjuvant chemoradiation tumor response immunohistochemistry genetic markers
Online Access:	https://www.siboncoj.ru/jour/article/view/408
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy
by: Daigo Kobayashi, et al.
Published: (2018-09-01)

Modern principles of neoadjuvant therapy for rectal cancer
by: A. M. Karachun, et al.
Published: (2025-05-01)

Sequencing of chemotherapy in total neoadjuvant treatment for rectal cancer does not predict radiation-induced lymphopenia
by: Orazem Miha, et al.
Published: (2025-06-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01)

COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY
by: S. O. Kochkina, et al.
Published: (2021-08-01)

Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
by: Velda Smajlbegović, et al.
Published: (2024-01-01)

Neoadjuvant chemotherapy versus long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of 5,168 cases
by: Wenjie Zhou, et al.
Published: (2025-06-01)

Impact of pathological complete response following neoadjuvant chemotherapy (gemcitabine, nab-paclitaxel, S-1) and radiation for borderline resectable pancreatic cancer: a case report and review of literature
by: Mitsuru Kinoshita, et al.
Published: (2022-09-01)

Effects of Neoadjuvant Chemio-Radiation Therapy on the Anal Sphincter Function in Patients with Low Rectal Cancers
by: A. B. Baichorov, et al.
Published: (2020-11-01)

Transanal endoscopic microsurgery in the treatment of patients with benign neoplasms and early rectal cancer
by: V. A. Avdeenko, et al.
Published: (2022-01-01)

Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review
by: R. E. Kalinin, et al.
Published: (2024-11-01)

Risk factors of pathologic complete response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Liangjing Zhou, et al.
Published: (2025-07-01)

Diagnostic Accuracy of Post-Neoadjuvant Treatment Restaging Magnetic Resonance Imaging in Rectal Cancer in the Era of Total Neoadjuvant Treatment
by: Gaurav Ravi Kumar, et al.
Published: (2025-05-01)

SURGICAL TREATMENT OF REGIONAL RECURRENCE FROM GASTRIC CANCER AFTER MULTIMODAL TREATMENT WITH NEOADJUVANT CHEMORADIOTHERAPY (A CASE REPORT)
by: V. Yu. Skoropad, et al.
Published: (2018-05-01)

RELATIONSHIP BETWEEN PARAMETERS OF TUMOR NEOANGIOGENESIS AND LYMPHOGENOUS METASTASIS IN PATIENTS WITH RECTAL CANCER
by: I. V. Stepanov, et al.
Published: (2017-07-01)

Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
by: WANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan
Published: (2025-04-01)

Dynamics of level of the tumor-associated marker SCCA in neoadjuvant superselective intra-arterial chemotherapy in patients with cervical squamous cell carcinoma
by: N. S. Sergeeva, et al.
Published: (2023-05-01)

PATHOLOGICAL RESPONSE OF GASTRIC CANCER TO NEOADJUVANT PROLONGED CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY
by: Е. F. Lushnikov, et al.
Published: (2016-02-01)

Altered levels of sphingolipid metabolites in serum of locally advanced rectal cancer patients: A pilot study
by: Bjelanović Jasna, et al.
Published: (2025-01-01)

Rectal-RadioSAM: Large model-assisted multi-parametric magnetic resonance imaging pipeline for predicting response to neoadjuvant chemoradiotherapy in rectal cancer without human intervention
by: Shao-Jun Xia, et al.
Published: (2025-07-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

MOLECULAR-GENETIC MARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH ANTHRACYCLINES IN BREAST CANCER PATIENTS
by: P. V. Kazantseva, et al.
Published: (2016-07-01)

CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy
by: Diana Lavinia Pricope, et al.
Published: (2025-05-01)

EGFR EXPRESSION IN RECTAL CANCER, RELATION TO THE FREAQUENCY OF LYMPH NODE METASTASIS
by: I. V. Stepanov, et al.
Published: (2017-06-01)

Baseline MRI habitat imaging for predicting treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Muzhen He, et al.
Published: (2025-07-01)

mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemother apy in locally advanced rectal cancer:a propensity score matching analysis
by: Qiu Meng
Published: (2022-04-01)

How Do MRI Findings Influence Rectal Cancer Management?
by: Ayloor Seshadri Ramakrishnan, et al.
Published: (2025-05-01)

Smoking and Elevated Preneoadjuvant Chemoradiotherapy Serum Carcinoembryonic Antigen Levels Are Associated With High Tumor Regression Grade and Poor Survival in Patients With Locally Advanced Rectal Cancer
by: Jen‐Pin Chuang, et al.
Published: (2025-06-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Implementation of Organ Preservation for Locally Advanced Rectal Cancer in Canada: A National Survey of Clinical Practice
by: Megan Delisle, et al.
Published: (2025-06-01)

Total Lesion Glycolysis (TLG) on 18F-FDG PET/CT as a Potential Predictor of Pathological Complete Response in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy: A Retrospective Study
by: Handan Tokmak, et al.
Published: (2025-07-01)

Short-term outcomes of preoperative chemotherapy in patients with upper ampullary rectal cancer
by: A. Yu. Dobrodeev, et al.
Published: (2022-01-01)

Complete remission of multiple liver metastases with only partial response of the primary rectal cancer after neoadjuvant chemotherapy
by: Satomi Miura, et al.
Published: (2020-02-01)

CANCER-EMBRYONIC ANTIGEN IN PREDICTING THERAPEUTIC TUMOR PATHOMORPHISM AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH RECTAL CANCER
by: D. V. Erygin, et al.
Published: (2018-06-01)

COLON AND RECTAL CANCER ARE DIFFERENT TUMOR ENTITIES ACCORDING TO EPIDEMIOLOGY, CARCINOGENESIS, MOLECULAR- AND TUMOR BIOLOGY, PRIMARY AND SECONDARY PREVENTION: PRECLINICAL EVIDENCE
by: S. Jafarov, et al.
Published: (2018-09-01)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

The modern views of the clinical, morphological and molecular biological predictors of breast cancer sensitivity to chemotherapy
by: E. Yu. Zubareva, et al.
Published: (2020-09-01)

Multimodal Preoperative Management of Rectal Cancer: A Review of the Existing Guidelines
by: Ionut Negoi
Published: (2025-06-01)